Position in BUDZ
as of Mar 31, 2023
· filed Dec 12, 2023
Position Value
$4,446
New position
Shares Held
74,111
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 2 holders
Holding Since
Mar 2023
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Fisher Asset Management, LLC holds $120,475,774 across 9 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,733,253 | $26,020,568 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
428,972 | $20,655,001 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,404 | $20,400,883 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
122,226 | $16,102,053 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
251,165 | $14,886,549 | |
| 6 | ALKS |
Alkermes plc.
|
390,479 | $13,807,337 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
364,745 | $5,051,718 | |
| 8 | HLN |
Haleon plc
|
327,131 | $3,274,581 |
All Filings in BUDZ
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2023-03-31 | $4,446 | 74,111 | Shares | Sole | 2023-12-12 | |
| No filing history on record for this holder in this stock. | ||||||